Scivanta Medical (OTCMKTS:SCVM) is a medical technology company specializing in the development and commercialization of noninvasive diagnostic solutions for cystic fibrosis and related pulmonary disorders. Founded in 2016 and headquartered in Oceanport, New Jersey, the company has built its core capabilities around proprietary microfluidic and sensor technologies designed to measure sweat chloride levels. By focusing on point-of-care platforms, Scivanta Medical aims to streamline patient screening, reduce testing times and enhance the accuracy of early disease detection.
The company’s flagship product is a handheld, smartphone-connected analyzer that leverages advanced microfluidics to collect and analyze sweat samples in under five minutes. Targeted primarily at neonatal screening programs and specialty clinics, the device integrates with Scivanta’s cloud-based data platform to enable secure record-keeping and longitudinal patient monitoring. In addition to its diagnostic system, Scivanta Medical is advancing a pipeline of complementary assays, including digital lung function monitoring tools and at-home testing kits aimed at improving patient adherence and remote care models.
Scivanta Medical operates across North America and Europe, where it has secured CE Mark certification and is in active dialogue with U.S. Food and Drug Administration officials regarding a 510(k) filing. The company maintains distribution partnerships with leading laboratory instrument suppliers and regional healthcare networks, and it has launched pilot programs in select Asia-Pacific markets. These initiatives underscore Scivanta’s strategy to build a global footprint through targeted regulatory approvals and collaborative agreements with academic research centers.
Leadership at Scivanta Medical is led by Dr. Imran Taweel, co-founder and chief executive officer, who brings more than 15 years of experience in diagnostic device development and commercialization. Chief financial officer Leah Maddock oversees strategic financing and investor relations, while the board of directors features seasoned industry executives in medtech and life sciences. Together, the management team is focused on advancing Scivanta’s growth trajectory through innovation, regulatory progress and strategic partnerships within the diagnostics landscape.
AI Generated. May Contain Errors.
